Mackay Shields LLC’s Intersect ENT, Inc XENT Stock Holding History

Mackay Shields LLC’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-46,700	Closed	-$762K	–	1630
2020 Q3	$762K	Sell	46,700 -4,200	-8%	-$76.1K	0.01%	1091
2020 Q2	$689K	Buy	+50,900	New	+$592K	0.01%	1124
2020 Q1	–	Sell	-12,100	Closed	-$301K	–	1537
2019 Q4	$301K	Buy	+12,100	New	+$245K	﹤0.01%	1229
2018 Q3	–	Sell	-30,800	Closed	-$1.15M	–	1258
2018 Q2	$1.15M	Sell	30,800 -7,600	-20%	-$298K	0.01%	916
2018 Q1	$1.51M	Buy	+38,400	New	+$1.4M	0.01%	872

Other funds holding XENT

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mackay Shields LLC's XENT Position: Q4 2020 in Review

Mackay Shields LLC sold out of Intersect ENT, Inc (XENT) in Q4 2020, closing a stake of 46,700 shares — an estimated $762K sold.

Mackay Shields LLC first reported a position in XENT in Q1 2018 and held it in 5 quarters. The position peaked at $1.51M in Q1 2018. 110 funds tracked by Wall St. Rank hold XENT as of Q4 2020.

Mackay Shields LLC reported no remaining Intersect ENT, Inc position as of Q4 2020 after selling out during the quarter.
Mackay Shields LLC sold 46,700 Intersect ENT, Inc shares in Q4 2020, an estimated $762K.
Mackay Shields LLC first reported a position in Intersect ENT, Inc in Q1 2018 and held it in 5 quarters.
Mackay Shields LLC's Intersect ENT, Inc position peaked at $1.51M in Q1 2018.
110 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2020.

Based on Mackay Shields LLC's 13F filing for Q4 2020, filed 16 Feb 2021.